22157.jpg
Benign Prostatic Hypertrophy Drug Market Projections: Industry Growth Forecast to 2028
12 févr. 2024 04h28 HE | Research and Markets
Dublin, Feb. 12, 2024 (GLOBE NEWSWIRE) -- The "Drugs For Benign Prostatic hypertrophy Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Benign Prostatic...
Global Pulmonary Arterial Hypertension (PAH) Drugs Market
Insights on the Pulmonary Arterial Hypertension (PAH) Drugs Global Market to 2027: Increasing Prevalence of Cardiovascular and Pulmonary Disorders Drives Growth
03 févr. 2023 04h58 HE | Research and Markets
Dublin, Feb. 03, 2023 (GLOBE NEWSWIRE) -- The "Pulmonary Arterial Hypertension (PAH) Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been...
FCL.png
Luigi Franciosi to Advise on New Asthma & COPD Drug Development Programs for Vicenna Pharmaceuticals Inc.
07 janv. 2020 12h30 HE | Franciosi Consulting Ltd.
VANCOUVER, British Columbia, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Franciosi Consulting Ltd. (“FCL”) is pleased to announce that its President and CEO, Dr. Luigi Franciosi, has been retained as a...
logo long.jpg
Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market to Surpass US$ 21.8 Billion by 2026
28 mai 2019 08h30 HE | CMI
SEATTLE, May 28, 2019 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, global chronic obstructive pulmonary disease (COPD) treatment market was valued at US$ 14,209.0 million in 2017 and...